SubQ-8

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameSubQ-8

Drug Alias NameSubcutaneous recombinant factor VIIISubcutaneous recombinant FVIIIhuman-cl rhFVIII/recombinant human von Willebrand Factor fragment dimerOCTA-101SubQ-8

ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant coagulation factor

Mechanisms of ActionCoagulation factor VIII replacementsCoagulation factor X stimulantsBlood coagulation pathway activation

TargetsCoagulation factor X

Therapy Area/IndicationsHemophilia A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryBulgaria

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesOctapharma

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesOctapharma

Active IndicationsN/A

Inactive IndicationsHemophilia A

Other Information

ATC CodeB02BD02